ESC 365 - Laboratory based risk assessment vs. clinical tools in risk prediction

Open Access

Laboratory based risk assessment vs. clinical tools in risk prediction

Session: Biomarkers for cardiovascular risk assessment: practical issues

Topic: Biomarkers

Speaker: Professor W. Maerz (Mannheim, DE)

Event: ESC Preventive Cardiology 2023

Congress Presentation

About the speaker

Professor Winfried Maerz

Institute of Public Health, Mannheim (Germany)

2 presentations

0 follower

5 more presentations in this session

Discussion – Laboratory based risk assessment vs. clinical tools in risk prediction

Laboratory test example: CoroPrevention score

Speaker: Doctor R. Laaksonen (Tampere, FI)

Discussion – Laboratory test example: CoroPrevention score

Would cost matter in laboratory test-based risk assessment?

Speaker: Mr D. Pollard (Sheffield, GB)

Discussion – Would cost matter in laboratory test-based risk assessment?

Access the full session

Biomarkers for cardiovascular risk assessment: practical issues

Speakers: Professor W. Maerz, Doctor R. Laaksonen, Mr D. Pollard

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by